HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 7.25
Day range
kr 7.15 - kr 7.45
Year range
kr 4.25 - kr 18.50
Market cap
371.32M SEK
Avg Volume
45.06K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.36M | — |
Operating expense | 11.83M | -4.43% |
Net income | -33.97M | 12.94% |
Net profit margin | -779.11 | — |
Earnings per share | — | — |
EBITDA | -27.52M | 24.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.60M | 21.14% |
Total assets | 159.72M | 16.87% |
Total liabilities | 155.09M | 158.82% |
Total equity | 4.63M | — |
Shares outstanding | 51.87M | — |
Price to book | 80.56 | — |
Return on assets | -48.39% | — |
Return on capital | -87.24% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.97M | 12.94% |
Cash from operations | 6.33M | 116.57% |
Cash from investing | — | — |
Cash from financing | 15.36M | 36,461.90% |
Net change in cash | 21.69M | 156.82% |
Free cash flow | 22.27M | 192.69% |
About
Founded
2013
Website
Employees
30
